Cargando…
Pivotal Considerations for Optimal Deployment of Healthy Volunteers in Oncology Drug Development
Oncology drug development is among the most challenging of any therapeutic area, with first‐in‐human trials expected to deliver information on both safety and activity. Until recently, therapeutic approaches in oncology focused on cytotoxic chemotherapy agents, ruling out even the possibility of enr...
Autores principales: | Ahmed, Mariam A., Patel, Chirag, Drezner, Nicole, Helms, Whitney, Tan, Weiwei, Stypinski, Daria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6951451/ https://www.ncbi.nlm.nih.gov/pubmed/31674150 http://dx.doi.org/10.1111/cts.12703 |
Ejemplares similares
-
Non-invasive computer navigation can quantify the pivot shift maneuver with good to excellent reliability in healthy volunteers
por: Monaco, Edoardo, et al.
Publicado: (2020) -
Healthy volunteers in first‐in‐human oncology drug development for small molecules
por: de las Heras, Begoña, et al.
Publicado: (2021) -
Dopamine transporter binding in symptomatic controls and healthy volunteers: Considerations for neuroimaging trials
por: Honkanen, Emma A., et al.
Publicado: (2021) -
Integration of healthy volunteers in early phase clinical trials with immuno-oncological compounds
por: Radanovic, Igor, et al.
Publicado: (2022) -
Pharmacokinetics and Scintigraphic Imaging of the Hypoxia-Imaging Agent [(123)I]IAZA in Healthy Adults Following Exercise-Based Cardiac Stress †
por: Stypinski, Daria, et al.
Publicado: (2018)